152 related articles for article (PubMed ID: 21626814)
1. [Antithrombotic therapy in the secondary prevention of stroke].
Mel'nikova EV; Kadinskaia MI; Gerasimenko DV; Shmonin AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12 Pt 2):23-7. PubMed ID: 21626814
[TBL] [Abstract][Full Text] [Related]
2. [Update on antithrombotic secondary prevention of ischemic stroke].
Köhrmann M; Kleinschnitz C
Nervenarzt; 2019 Oct; 90(10):995-1004. PubMed ID: 31560112
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention by stroke subtype: a nationwide follow-up study in 46 108 patients after acute ischaemic stroke.
Kim D; Lee SH; Joon Kim B; Jung KH; Yu KH; Lee BC; Roh JK;
Eur Heart J; 2013 Sep; 34(35):2760-7. PubMed ID: 23729692
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
Davis SM; Donnan GA
N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
[No Abstract] [Full Text] [Related]
5. Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel.
Del Brutto VJ; Chaturvedi S; Diener HC; Romano JG; Sacco RL
J Am Coll Cardiol; 2019 Aug; 74(6):786-803. PubMed ID: 31395130
[TBL] [Abstract][Full Text] [Related]
6. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
Weber R; Weimar C; Diener HC
Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet treatment in the secondary prevention of coronary and cerebrovascular disease: is there any place for novel agents?
Ntalas IV; Milionis HJ; Kei AA; Kalantzi KI; Goudevenos JA
Angiology; 2014 Jul; 65(6):473-90. PubMed ID: 23966569
[TBL] [Abstract][Full Text] [Related]
8. Filling the gap between science & clinical practice: prevention of stroke recurrence.
Russolillo A; Di Minno MN; Tufano A; Prisco D; Di Minno G
Thromb Res; 2012 Jan; 129(1):3-8. PubMed ID: 21907395
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet, anticoagulant and fibrinolytic agents in acute ischaemic stroke and TIA.
Sandercock P; Lindley R; Wardlaw J
Br J Hosp Med; 1992 May 20-Jun 2; 47(10):731-7. PubMed ID: 1606457
[TBL] [Abstract][Full Text] [Related]
10. Stroke subtypes and interventional studies for transient ischemic attack.
Lavallée P; Amarenco P
Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
[TBL] [Abstract][Full Text] [Related]
11. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study.
Volpato S; Maraldi C; Blè A; Ranzini M; Rita Atti A; Dominguez LJ; Barbagallo M; Fellin R; Zuliani G;
Stroke; 2004 Apr; 35(4):913-7. PubMed ID: 15001787
[TBL] [Abstract][Full Text] [Related]
12. The role of antithrombotics in secondary stroke prevention.
Lazzaro MA; Malhotra K; Mohammad YM
Semin Neurol; 2010 Nov; 30(5):492-500. PubMed ID: 21207341
[TBL] [Abstract][Full Text] [Related]
13. 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack.
Wang Y; Liu M; Pu C
Int J Stroke; 2017 Apr; 12(3):302-320. PubMed ID: 28381199
[TBL] [Abstract][Full Text] [Related]
14. Secondary stroke prevention: review of clinical trials.
Elkind MS
Clin Cardiol; 2004 May; 27(5 Suppl 2):II25-35. PubMed ID: 15188933
[TBL] [Abstract][Full Text] [Related]
15. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
[TBL] [Abstract][Full Text] [Related]
16. [Modern strategies for the management of patients who have suffered ischemic stroke or transient ischemic attack].
Shirokov EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12. Vyp. 2):61-67. PubMed ID: 38148699
[TBL] [Abstract][Full Text] [Related]
17. Preventing recurrent cerebrovascular events in patients with stroke or transient ischemic attack: the current data.
Bergman D
J Am Acad Nurse Pract; 2011 Dec; 23(12):659-66. PubMed ID: 22145656
[TBL] [Abstract][Full Text] [Related]
18. Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.
Kaplan ED; Sacco RL
Curr Neurol Neurosci Rep; 2002 Jan; 2(1):31-7. PubMed ID: 11898580
[TBL] [Abstract][Full Text] [Related]
19. Oral anticoagulants and non-cardioembolic stroke prevention.
Schachter ME; Tran HA; Anand SS
Vasc Med; 2008 Feb; 13(1):55-62. PubMed ID: 18372441
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.
Larsen TB; Rasmussen LH; Gorst-Rasmussen A; Skjøth F; Lane DA; Lip GY
Am J Med; 2014 Dec; 127(12):1172-8.e5. PubMed ID: 25193361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
